Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 15;8(11):e80513.
doi: 10.1371/journal.pone.0080513. eCollection 2013.

Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936

Affiliations

Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936

Donald M Lyall et al. PLoS One. .

Abstract

The APOE ε and TOMM40 rs10524523 ('523') variable length poly-T repeat gene loci have been significantly and independently associated with Alzheimer's disease (AD) related phenotypes such as age of clinical onset. Hippocampal atrophy has been significantly associated with memory impairment, a characteristic of AD. The current study aimed to test for independent effects of APOE ε and TOMM40 '523' genotypes on hippocampal volumes as assessed by brain structural MRI in a relatively large sample of community-dwelling older adults. As part of a longitudinal study of cognitive ageing, participants in the Lothian Birth Cohort 1936 underwent genotyping for APOE ε2/ε3/ε4 status and TOMM40 '523' poly-T repeat length, and detailed structural brain MRI at a mean age of 72.7 years (standard deviation = 0.7, N range = 624 to 636). No significant effects of APOE ε or TOMM40 523 genotype were found on hippocampal volumes when analysed raw, or when adjusted for either intracranial or total brain tissue volumes. In summary, in a large community-dwelling sample of older adults, we found no effects of APOE ε or TOMM40 523 genotypes on hippocampal volumes. This is discrepant with some previous reports of significant association between APOE and left/right hippocampal volumes, and instead echoes other reports that found no association. Previous significant findings may partly reflect type 1 error. Future studies should carefully consider: 1) their specific techniques in adjusting for brain size; 2) assessing more detailed sub-divisions of the hippocampal formation; and 3) testing whether significant APOE-hippocampal associations are independent of generalised brain atrophy.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: ADR is the CEO and only stock holder of Zinfandel Pharmaceuticals, a company in an Alliance with Takeda Pharmaceuticals, to perform the prospective qualification of the TOMM40 marker for age of onset distribution of Alzheimer’s Disease. For this study, Zinfandel Pharmaceuticals paid for the TOMM40 assays to be performed for medical research, not as a clinical diagnostic. AMS is the spouse of ADR, and AMS and WML are consultants to Zinfandel Pharmaceuticals. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

References

    1. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F et al. (2009) Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptiblity genes for Alzheimer's disease. PLOS ONE 1. doi:10.1371/journal.pone.0006501. - DOI - PMC - PubMed
    1. Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG et al. (2006) Reduced hippocampal volume in non-demented carriers of the apolipoprotein e4: relation to chronological age and recognition memory. Neurosci Lett 396: 23 - 27. doi:10.1016/j.neulet.2005.11.070. PubMed: 16406347. - DOI - PubMed
    1. Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG et al. (2010) A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer’s disease. Pharmacogenomics J 10: 375 - 384. doi:10.1038/tpj.2009.69. PubMed: 20029386. - DOI - PMC - PubMed
    1. NCBI APOE. information (2012). Available http://www.ncbi.nlm.nih.gov/gene/348. Accessed 26.08.2012.
    1. Ringman JM, Cummings JL (2009) The Genetic Basis for the Cognitive Deterioration of Alzheimer’s Disease. In: Goldberg te Weinberger D. The Genetics of Cognitive Neuroscience. Massachusetts: MIT Press; pp. 221 - 244.

Publication types

Substances